Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 5Carcinoma, Renal Cell 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 2Lung Neoplasms 2Urogenital Neoplasms 1Solid Tumor, Adult 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Kidney Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

sapanisertib 1pertuzumab 1fludarabine phosphate 1fludarabine 1aldesleukin 1Trastuzumab 1Radiotherapy 1Mesna 1Interleukin-2 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Meningeal Neoplasms × Interleukin-2 × Clear all
NCT00338377 2026-03-20

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
1,230 enrolled
Dermatologic

Melanoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡